Skip to content

Supplier News

Avella to distribute Braftovi and Mektovi

Avella to distribute Braftovi and Mektovi

Avella has announced that it will distribute Braftovi (encorafenib and Mektovi (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma.

Aurobindo launches atazanavir capsules

Aurobindo launches atazanavir capsules

Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.

Upsher-Smith featuring Platinum Pass at AHS meeting

Upsher-Smith featuring Platinum Pass at AHS meeting

Upsher-Smith Laboratories (Upsher-Smith)  announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28  to  July 1,  in 

FDA grants priority review to single-dose flu drug

FDA grants priority review to single-dose flu drug

Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.

Aurobindo receives FDA approval for ertapenem injection

Aurobindo receives FDA approval for ertapenem injection

Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.

Dove making a new mark in beauty imagery

Dove making a new mark in beauty imagery

Starting next month, Dove will be taking another step in ensuring beauty is a source of confidence and not anxiety with the launch of a ‘No Digital Distortion Mark’. The Mark will roll out across all branded content globally beginning in July with deodorant campaigns leading the initiative.